chuminhua2019-01-03 23:08
$Ohr制药(OHRP)$
12/3,NeuBase Therapeutics通过反向收购Ohr Pharmaceutical,在纳斯达克上市。NeuBase的模块化反义肽核酸(PNA)平台PATrOL用于改善基因沉默疗法。网页链接查看全文
$OHR PHARMACEUTICAL INC(OHRP)$ 内部交易: 2016-06-20,CFO,Backenroth Samuel ,买入,2468普通股, $2.84
$OHR PHARMACEUTICAL INC(OHRP)$ 内部交易: 2016-06-20,CEO,Slakter Jason Scott ,买入,8786普通股, $2.85
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2016-05-10 AccNo: 0001387131-16-005362 Size: 330 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-05-10 AccNo: 0001387131-16-005359 Size: 2 MB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 美东时间 2016-05-10 16:30 After Market Close:OHR PHARMACEUT Earning Release 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 内部交易: 2016-04-11,CEO,Slakter Jason Scott ,买入,6250普通股, $3.35
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2016-03-29 AccNo: 0001387131-16-004745 Size: 40 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2016-03-21 AccNo: 0001387131-16-004644 Size: 244 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07:...
$OHR PHARMACEUTICAL INC(OHRP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-16 AccNo: 0000919574-16-010752 Size: 119 KB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-12 AccNo: 0001387131-16-004170 Size: 185 KB 网页链接